Original Research
Published on 14 Oct 2021
NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.688794
- 4,793 views
- 11 citations
Type at least 3 characters
909 articles
Articles
Review
Published on 14 Oct 2021
Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.675972
- 9,635 views
- 28 citations
Original Research
Published on 07 Oct 2021
Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.681872
- 3,979 views
- 7 citations
Original Research
Published on 07 Oct 2021
HPV16 E6 Promotes the Progression of HPV Infection-Associated Cervical Cancer by Upregulating Glucose-6-Phosphate Dehydrogenase Expression
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.718781
- 3,623 views
- 8 citations
Original Research
Published on 06 Oct 2021
Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.753910
- 2,111 views
- 4 citations
Original Research
Published on 05 Oct 2021
Detection of HPV and Human Chromosome Sites by Dual-Color Fluorescence In Situ Hybridization Reveals Recurrent HPV Integration Sites and Heterogeneity in Cervical Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.734758
- 4,231 views
- 6 citations
Original Research
Published on 04 Oct 2021
The Risk Stratification for Cervical Cancer and Precursors of Domestic HPV Testing With HPV 16/18 Genotyping in Women With NILM Cytology in CentralChina: A Cohort Study
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.716762
- 2,888 views
- 4 citations
Original Research
Published on 04 Oct 2021
Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.744256
- 3,251 views
- 9 citations
Original Research
Published on 04 Oct 2021
High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.742017
- 4,009 views
- 7 citations
Original Research
Published on 30 Sep 2021
Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.754094
- 3,647 views
- 5 citations
Review
Published on 24 Sep 2021
Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.745808
- 5,594 views
- 10 citations
Original Research
Published on 24 Sep 2021
Application of Single-Port Laparoscopic Surgery in Myomectomy
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.722084
- 2,995 views
- 8 citations
Original Research
Published on 24 Sep 2021
Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.741071
- 4,144 views
- 16 citations
Original Research
Published on 23 Sep 2021
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.713026
- 3,598 views
- 5 citations
Systematic Review
Published on 23 Sep 2021
Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.694821
- 5,005 views
- 12 citations
Review
Published on 23 Sep 2021
Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.674637
- 3,875 views
- 5 citations